Gender differences in ocular blood flow

Current Eye Research

Volumn 40, Issue 2, 2015, Pages 201-212

  Schmidl, Doreen ^a   Schmetterer, Leopold ^a,b   Garhöfer, Gerhard ^a   Popa Cherecheanu, Alina ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Age related macular degeneration; Diabetic retinopathy; Gender; Glaucoma; Ocular blood flow

Indexed keywords

ESTROGEN; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

AGE RELATED MACULAR DEGENERATION; BLOOD VESSEL TONE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE BLOOD FLOW; EYE DISEASE; GLAUCOMA; HORMONAL THERAPY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; VASCULAR DISEASE; VASCULAR RESISTANCE; BLOOD FLOW; BLOOD FLOW VELOCITY; CHOROID; EYE; FEMALE; HUMAN; MACULAR DEGENERATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; VASCULARIZATION;

BLOOD FLOW VELOCITY; CHOROID; DIABETIC RETINOPATHY; EYE; FEMALE; GLAUCOMA; HUMANS; MACULAR DEGENERATION; MALE; REGIONAL BLOOD FLOW; RETINA; SEX FACTORS;

EID: 84921662535     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.906625     Document Type: Review

References (184)

1. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: A task for the third millennium. Clin Chem Lab Med 2013;51:713-727.
2. Maas AH, van der Schouw YT, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, et al. Red alert for women's heart: The urgent need for more research and knowledge on cardiovascular disease in women: Proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 2011;32:1362-1368.
3. Schmetzer O, Florcken A. Sex differences in the drug therapy for oncologic diseases. Handb Exp Pharmacol 2012;214:411-442.
4. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008;83:1-10.
5. Riva CE, Schmetterer L. Microcirculation of the ocular fundus. In: Tuma RF, Durán WN, Ley K, editors. Handbook of Physiology: Microcirculation. 2 ed. Amsterdam: Academic Press; 2008. pp 735-765.
6. Pournaras CJ, Rungger-Brandle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008;27:284-330.
7. Kur J, Newman EA, Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Retin Eye Res 2012;31:377-406.
8. Schmetterer L, Kiel J. Ocular blood flow. New York: Springer; 2012.
9. Pournaras CJ, Riva CE. Retinal blood flow evaluation. Ophthalmologica 2013;229:61-74.
10. Newman EA. Functional hyperemia and mechanisms of neurovascular coupling in the retinal vasculature. J Cereb Blood Flow Metab 2013;33:1685-1695.
11. Luksch A, Polska E, Imhof A, Schering J, Fuchsjager-Mayrl G, Wolzt M, et al. Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci 2003;44:734-739.
12. Fuchsjager-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, Schmetterer L. Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci 2003;44:728-733.
13. Schmidl D, Boltz A, Kaya S, Werkmeister R, Dragostinoff N, Lasta M, et al. Comparison of choroidal and optic nerve head blood flow regulation during changes in ocular perfusion pressure. Invest Ophthalmol Vis Sci 2012;53: 4337-4346.
14. Garhofer G, Bek T, Boehm AG, Gherghel D, Grunwald J, Jeppesen P, et al. Use of the retinal vessel analyzer in ocular blood flow research. Acta Ophthalmol 2010;88:717-722.
15. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, et al. Prediction of incident stroke events based on retinal vessel caliber: A systematic review and individualparticipant meta-analysis. Am J Epidemiol 2009;170: 1323-1332.
16. Kawasaki R, Xie J, Cheung N, Lamoureux E, Klein R, Klein BE, et al. Retinal microvascular signs and risk of stroke: The Multi-Ethnic Study of Atherosclerosis (MESA). Stroke 2012;43:3245-3251.
17. Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 2012;60:1094-1103.
18. Nguyen TT, Wong TY. Retinal vascular changes and diabetic retinopathy. Curr Diab Rep 2009;9:277-283.
19. Kawasaki R, Wang JJ, Rochtchina E, Lee AJ, Wong TY, Mitchell P. Retinal vessel caliber is associated with the 10-year incidence of glaucoma: The Blue Mountains Eye Study. Ophthalmology 2013;120:84-90.
20. Riva CE, Grunwald JE, Sinclair SH, Petrig BL. Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci 1985;26:1124-1132.
21. Garhofer G,Werkmeister R, Dragostinoff N, Schmetterer L. Retinal blood flow in healthy young subjects. Invest Ophthalmol Vis Sci 2012;53:698-703.
22. Rechtman E, Harris A, Kumar R, Cantor LB, Ventrapragada S, Desai M, et al. An update on retinal circulation assessment technologies. Curr Eye Res 2003;27: 329-343.
23. Stalmans I, Vandewalle E, Anderson DR, Costa VP, Frenkel RE, Garhofer G, et al. Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol 2011;89: E609-630.
24. Silver DM, Farrell RA. Validity of pulsatile ocular blood flow measurements. Surv Ophthalmol 1994;38:S72-80.
25. Schmetterer L, Dallinger S, Findl O, Eichler HG, Wolzt M. A comparison between laser interferometric measurement of fundus pulsation and pneumotonometric measurement of pulsatile ocular blood flow. 1. Baseline considerations. Eye (Lond) 2000;14:39-45.
26. Wang Y, Bower BA, Izatt JA, Tan O, Huang D. In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography. J Biomed Opt 2007;12:041215.
27. Wang Y, Lu A, Gil-Flamer J, Tan O, Izatt JA, Huang D. Measurement of total blood flow in the normal human retina using Doppler Fourier-domain optical coherence tomography. Br J Ophthalmol 2009;93:634-637.
28. Baumann B, Potsaid B, Kraus MF, Liu JJ, Huang D, Hornegger J, et al. Total retinal blood flow measurement with ultrahigh speed swept source/Fourier domain OCT. Biomed Opt Express 2011;2:1539-1552.
29. Choi W, Baumann B, Liu JJ, Clermont AC, Feener EP, Duker JS, et al. Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT. Biomed Opt Express 2012;3: 1047-1061.
30. Werkmeister RM, Dragostinoff N, Palkovits S, Told R, Boltz A, Leitgeb RA, et al. Measurement of absolute blood flow velocity and blood flow in the human retina by dualbeam bidirectional Doppler Fourier-Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci 2012;53:6062-6071.
31. Dai C, Liu X, Zhang HF, Puliafito CA, Jiao S. Absolute retinal blood flow measurement with a dual-beam Doppler optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:7998-8003.
32. Doblhoff-Dier V, Schmetterer L, Vilser W, Garhofer G, Gröschl M, Leitgeb RA, et al. Measurement of the total retinal blood flow using dual beam Fourier-domain Doppler optical coherence tomography with orthogonal detection planes. Biomed Opt Express 2014;5:630-642.
33. Justice Jr J, Lehmann RP. Cilioretinal arteries. A study based on review of stereo fundus photographs and fluorescein angiographic findings. Arch Ophthalmol 1976;94:1355-1358.
34. McLeod D. Central retinal vein occlusion with cilioretinal infarction from branch flow exclusion and choroidal arterial steal. Retina 2009;29:1381-1395.
35. Hayreh SS. Acute retinal arterial occlusive disorders. Prog Retin Eye Res 2011;30:359-394.
36. Riva CE, Geiser M, Petrig BL. Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmol 2010;88:622-629.
37. Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S. Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol 2010;88:723-729.
38. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 1999;42:387-405.
39. Clermont AC, Bursell SE. Retinal blood flow in diabetes. Microcirculation 2007;14:49-61.
40. Pemp B, Schmetterer L. Ocular blood flow in diabetes and age-related macular degeneration. Can J Ophthalmol 2008; 43:295-301.
41. Durham JT, Herman IM. Microvascular modifications in diabetic retinopathy. Curr Diab Rep 2011;11:253-264.
42. Lasta M, Pemp B, Schmidl D, Boltz A, Kaya S, Palkovits S, et al. Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2013;54:842-847.
43. Ehrlich R, Kheradiya NS, Winston DM, Moore DB, Wirostko B, Harris A. Age-related ocular vascular changes. Graefes Arch Clin Exp Ophthalmol 2009;247:583-591.
44. Feigl B. Age-related maculopathy-linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res 2009;28:63-86.
45. Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow-relevance for glaucoma. Exp Eye Res 2011;93: 141-155.
46. Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol 2013;13:36-42.
47. Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol 2013;13:43-49.
48. Costa VP, Harris A, Anderson D, Stodtmeister R, Cremasco F, Kergoat H, et al. Ocular perfusion pressure in glaucoma. Acta Ophthalmol 2013. [epub ahead of print].
49. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25:S13-15.
50. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: A meta-analysis. Ophthalmology 2012; 119:571-580.
51. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
52. You QS, Xu L, Yang H, Li YB, Wang S, Wang JD, et al. Fiveyear incidence of age-related macular degeneration: The Beijing Eye Study. Ophthalmology 2012;119:2519-2525.
53. Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB,Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: A systematic review and meta-analysis. Ophthalmology 2010;117:921-927.
54. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: A Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006;47:4254-4261.
55. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-1669.
56. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. American Journal of Ophthalmology 2001;131: 699-708.
57. Wang YE, Li Y, Wang D, He M, Lin S. Comparison of factors associated with occludable angle between american Caucasians and ethnic Chinese. Invest Ophthalmol Vis Sci 2013;54:7717-7723.
58. Kashiwagi K, Chiba T, Mabuchi F, Furuya T, Tsukahara S. Five-year incidence of angle closure among glaucoma health examination participants. Graefes Arch Clin Exp Ophthalmol 2013;251:1219-1228.
59. Xu L, You QS, Wang YX, Jonas JB. Associations between gender, ocular parameters and diseases: The Beijing Eye study. Ophthalmic Res 2011;45:197-203.
60. Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: What we know and what we need to know. Curr Opin Ophthalmol 2010;21:91-99.
61. Cheng JW, Cheng SW, Ma XY, Cai JP, Li Y, Wei RL. The prevalence of primary glaucoma in mainland China: A systematic review and meta-analysis. J Glaucoma 2013;22: 301-306.
62. Xie XW, Xu L, Wang YX, Jonas JB. Body height and ocular diseases. The Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol 2009;247:1651-1657.
63. Hsieh YT, Shen EP, Hsu WC. Is being female a risk factor for shallow anterior chamber? The associations between anterior chamber depth and age, sex, and body height. Indian J Ophthalmol 2013. [epub ahead of print].
64. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649-656.
65. Kostev K, Rathmann W. Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: A database analysis. Diabetologia 2013;56:109-111.
66. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW. Diabetic retinopathy in type 1 diabetes-A contemporary analysis of 8,784 patients. Diabetologia 2011;54: 1977-1984.
67. Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311-318.
68. Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol 2011;89: 515-521.
69. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: The CoLaus study. Diabet Med 2012;29:190-197.
70. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481-497.
71. Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A, et al. Type 2 diabetes from pediatric to geriatric age: Analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 2012;167:245-254.
72. Cunningham-Myrie C, Younger-Coleman N, Tulloch-Reid M, McFarlane S, Francis D, Ferguson T, et al. Diabetes mellitus in Jamaica: Sex differences in burden, risk factors, awareness, treatment and control in a developing country. Trop Med Int Health 2013;18:1365-1378.
73. Walton RC, Ashmore ED. Retinal vasculitis. Curr Opin Ophthalmol 2003;14:413-419.
74. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2:119-125.
75. Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, et al. Patterns of systemic lupus erythematosus expression in Europe. Autoimmun Rev 2014;13:621-629.
76. Zou YF, Feng CC, Zhu JM, Tao JH, Chen GM, Ye QL, et al. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province. Rheumatol Int 2014;34:347-356.
77. Rothschild PR, Pagnoux C, Seror R, Brezin AP, Delair E, Guillevin L. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: A retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum 2013;42:507-514.
78. Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology 2004;111:357-62.
79. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: A comprehensive review and update for the dermatologist: Part I. Cutaneous disease. J Am Acad Dermatol 2012;66:699 e1-18 (quiz 717-8).
80. Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: Systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 2012;51:887-900.
81. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007;55:173-183.
82. Rothova A, Berendschot TT, Probst K, van Kooij B, Baarsma GS. Birdshot chorioretinopathy: Long-term manifestations and visual prognosis. Ophthalmology 2004;111:954-959.
83. Stem MS, Talwar N, Comer GM, Stein JD. A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 2013;120:362-370.
84. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117:313-9 e1.
85. Wong TY, Klein R. Retinal arteriolar emboli: Epidemiology and risk of stroke. Curr Opin Ophthalmol 2002;13:142-146.
86. Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. Am J Ophthalmol 2011;152:820-3 e2.
87. Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: A systematic review and metaanalysis. BMC Ophthalmol 2010;10:31.
88. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-253.
89. Abramov Y, Borik S, Yahalom C, Fatum M, Avgil G, Brzezinski A, et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause 2004;11:62-68.
90. Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C. Sex steroids and age-related macular degeneration in older French women: The POLA study. Ann Epidemiol 2004;14:202-208.
91. Seitzman RL, Mangione C, Ensrud KE, Cauley JA, Stone KL, Cummings SR, et al. Postmenopausal hormone therapy and age-related maculopathy in older women. Ophthalmic Epidemiol 2008;15:308-316.
92. Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008;126:519-524.
93. Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H, Njolstad I. Lactation, female hormones and age-related macular degeneration: The Tromso Study. Br J Ophthalmol 2013;97:1036-1039.
94. Tamer C, Oksuz H, Sogut S. Serum dehydroepiandrosterone sulphate level in age-related macular degeneration. Am J Ophthalmol 2007;143:212-216.
95. Ulas F, Balbaba M, Ozmen S, Celebi S, Dogan U. Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with agerelated macular degeneration. Int Ophthalmol 2013;33: 485-491.
96. Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: Implications for eye diseases. EPMA J 2013;4:14.
97. Vajaranant TS, Pasquale LR. Estrogen deficiency accelerates aging of the optic nerve. Menopause 2012;19:942-947.
98. Tint NL, Alexander P, Tint KM, Vasileiadis GT, Yeung AM, Azuara-Blanco A. Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 2010;17: 157-160.
99. Sator MO, Joura EA, Frigo P, Kurz C, Metka M, Hommer A, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-58.
100. Hulsman CA, Westendorp IC, Ramrattan RS, Wolfs RC, Witteman JC, Vingerling JR, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001;154:138-144.
101. Lee AJ, Mitchell P, Rochtchina E, Healey PR. Female reproductive factors and open angle glaucoma: The Blue Mountains Eye Study. Br J Ophthalmol 2003;87: 1324-1328.
102. Vajaranant TS, Grossardt BR, Maki PM, Pasquale LR, Sit AJ, Shuster LT, et al. Risk of glaucoma after early bilateral oophorectomy. Menopause 2014;21:391-398.
103. Errera MH, Kohly RP, da Cruz L. Pregnancy-associated retinal diseases and their management. Surv Ophthalmol 2013;58:127-142.
104. Negrato CA, Mattar R, Gomes MB. Adverse pregnancy outcomes in women with diabetes. Diabetol Metab Syndr 2012;4:41.
105. Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand 2000;79:367-370.
106. Sone H, Okuda Y, Kawakami Y, Kondo S, Hanatani M, Matsuo K, et al. Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sci 1996;59:21-25.
107. Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, et al. Diabetic retinopathy and VEGF. Open Ophthalmol J 2013;7:4-10.
108. Klein BE, Klein R, Moss SE. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999;22:1984-1987.
109. Chaurasia RK, Singh R, Agrawal JK, Maurya OP. Sex hormones and diabetic retinopathy. Ann Ophthalmol 1993;25:227-230.
110. Haffner SM, Klein R, Dunn JF, Moss SE, Klein BE. Increased testosterone in type I diabetic subjects with severe retinopathy. Ophthalmology 1990;97:1270-1274.
111. Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, et al. Different combined oral contraceptives and the risk of venous thrombosis: Systematic review and network metaanalysis. BMJ 2013;347:f5298.
112. Rott H. Thrombotic risks of oral contraceptives. Curr Opin Obstet Gynecol 2012;24:235-240.
113. Main C, Knight B, Moxham T, Gabriel Sanchez R, Sanchez Gomez LM, Roque i Figuls M, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2013;4:CD002229.
114. Holmegard HN, Nordestgaard BG, Schnohr P, Tybjaerg-Hansen A, Benn M. Endogenous sex hormones and risk of venous thromboembolism in women and men. J Thromb Haemost 2014;12:297-305.
115. Tormene D, Ferri V, Carraro S, Simioni P. Gender and the risk of venous thromboembolism. Semin Thromb Hemost 2011;37:193-198.
116. Aggarwal RS, Mishra VV, Aggarwal SV. Oral contraceptive pills: A risk factor for retinal vascular occlusion in invitro fertilization patients. J Hum Reprod Sci 2013;6:79-81.
117. Thapa R, Paudyal G. Central retinal vein occlusion in young women: Rare cases with oral contraceptive pills as a risk factor. Nepal Med Coll J 2009;11:209-11.
118. Vessey MP, Hannaford P, Mant J, Painter R, Frith P, Chappel D. Oral contraception and eye disease: Findings in two large cohort studies. Br J Ophthalmol 1998;82: 538-542.
119. Murray DC, Christopoulou D, Hero M. Combined central retinal vein occlusion and cilioretinal artery occlusion in a patient on hormone replacement therapy. Br J Ophthalmol 2000;84:549-550.
120. Cahill M, O'Toole L, Acheson RW. Hormone replacement therapy and retinal vein occlusion. Eye (Lond) 1999;13: 798-800.
121. Mehta C. Central retinal artery occlusion and oral contraceptives. Indian J Ophthalmol 1999;47:35-36.
122. Rekhi GS, Dheer S. Oral contraceptive-induced central retinal artery occlusion. J Assoc Physicians India 2002;50: 1084-1085.
123. Burgansky-Eliash Z, Barash H, Nelson D, Grinvald A, Sorkin A, Loewenstein A, et al. Retinal blood flow velocity in patients with age-related macular degeneration. Curr Eye Res 2014;39:304-311.
124. Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG. Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 2005;46:1033-1038.
125. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 1995;102:640-646.
126. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:358-363.
127. Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, Frantal S, et al. Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 2010;51:4220-4225.
128. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, Rainer G, Kircher K, Buehl W, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004;45:834-839.
129. Meng N, Zhang P, Huang H, Ma J, Zhang Y, Li H, et al. Color Doppler imaging analysis of retrobulbar blood flow velocities in primary open-angle glaucomatous eyes: A meta-analysis. PLoS One 2013;8:e62723.
130. Michelson G, Langhans MJ, Groh MJ. Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma. J Glaucoma 1996;5:91-98.
131. Findl O, Rainer G, Dallinger S, Dorner G, Polak K, Kiss B, et al. Assessment of optic disk blood flow in patients with open-angle glaucoma. Am J Ophthalmol 2000;130: 589-596.
132. Venkataraman ST, Flanagan JG, Hudson C. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma-A review. Microcirculation 2010;17:568-581.
133. Pemp B, Polska E, Garhofer G, Bayerle-Eder M, Kautzky-Willer A, Schmetterer L. Retinal blood flow in type 1 diabetic patients with no or mild diabetic retinopathy during euglycemic clamp. Diabetes Care 2010;33: 2038-2042.
134. Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. BMJ 1992;305:678-683.
135. Schmetterer L, Salomon A, Rheinberger A, Unfried C, Lexer F, Wolzt M. Fundus pulsation measurements in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1997;235:283-287.
136. Gracner T. Ocular blood flow velocity determined by color Doppler imaging in diabetic retinopathy. Ophthalmologica 2004;218:237-242.
137. Garhofer G, Zawinka C, Resch H, Kothy P, Schmetterer L, Dorner GT. Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 2004;88:887-891.
138. Mandecka A, Dawczynski J, Blum M, Muller N, Kloos C, Wolf G, et al. Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 2007;30: 3048-3052.
139. Pemp B, Garhofer G, Weigert G, Karl K, Resch H, Wolzt M, et al. Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. Invest Ophthalmol Vis Sci 2009;50: 4029-4032.
140. Lecleire-Collet A, Audo I, Aout M, Girmens JF, Sofroni R, Erginay A, et al. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 2011;52:2861-2867.
141. Oner A, Akal A, Erdogan N, Dogan H, Oner M. Color Doppler imaging of ocular hemodynamic changes in Behcet disease and uveitis patients with different etiologies. Curr Eye Res 2006;31:519-523.
142. Akcar N, Goktekin F, Ozer A, Korkmaz C. Doppler sonography of ocular and carotid arteries in Behcet patients. J Clin Ultrasound 2010;38:486-492.
143. Isik C, Yagci B, Yildirim C, Yaylali V, Tatlipinar S, Ozden S. Orbital color Doppler imaging in Behcet's disease with or without ocular involvement. Int Ophthalmol 2007;27: 37-42.
144. Ozdemir H, Atilla H, Atilla S, Isik S, Zilelioglu G. Diagnosis of ocular involvement in Behcet's disease: Value of spectral and color Doppler sonography. AJR Am J Roentgenol 1995;164:1223-1227.
145. Caca I, Nazaroglu H, Unlu K, Cakmak SS, Ari S, Sakalar YB. Color doppler imaging of ocular hemodynamic changes in Behcet's disease. Jpn J Ophthalmol 2004;48: 101-5.
146. Arsene S, Giraudeau B, Le Lez ML, Pisella PJ, Pourcelot L, Tranquart F. Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol 2002;86:1243-1247.
147. Keyser BJ, Flaharty PM, Sergott RC, Brown GC, Lieb WE, Annesley Jr WH,. Color Doppler imaging of arterial blood flow in central retinal vein occlusion. Ophthalmology 1994;101:1357-1361.
148. Tranquart F, Arsene S, Giraudeau B, Piquemal R, Eder V, Le Lez ML, et al. Initial color Doppler findings in retinal vein occlusion. J Clin Ultrasound 2000;28:28-33.
149. Wang Y, Fawzi AA, Varma R, Sadun AA, Zhang X, Tan O, et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci 2011;52: 840-845.
150. Fujio N, Feke GT, Ogasawara H, Goger DG, Yoshida A, McMeel JW. Quantitative circulatory measurements in branch retinal vessel occlusion. Eye (Lond) 1994;8: 324-328.
151. Avila Jr. CP, Bartsch DU, Bitner DG, Cheng L, Mueller AJ, Karavellas MP, et al. Retinal blood flow measurements in branch retinal vein occlusion using scanning laser Doppler flowmetry. Am J Ophthalmol 1998;126:683-690.
152. Luksch A, Maar N, Tittl M, Ergun E, Findl O, Stur M, et al. Evaluation of pulsatile choroidal blood flow in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:548-550.
153. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, de Jong PT. Retinal vessel diameters and the risk of incident age-related macular disease: The Rotterdam Study. Ophthalmology 2005;112:548-552.
154. Liew G, Kaushik S, Rochtchina E, Tan AG, Mitchell P, Wang JJ. Retinal vessel signs and 10-year incident agerelated maculopathy: The Blue Mountains Eye Study. Ophthalmology 2006;113:1481-1487.
155. Wang S, Xu L, Wang Y, Jonas JB. Retinal vessel diameter in normal and glaucomatous eyes: The Beijing eye study. Clin Experiment Ophthalmol 2007;35:800-7.
156. Ikram MK, de Voogd S, Wolfs RC, Hofman A, Breteler MM, Hubbard LD, et al. Retinal vessel diameters and incident open-angle glaucoma and optic disc changes: The Rotterdam study. Invest Ophthalmol Vis Sci 2005;46: 1182-1187.
157. Klein R, Myers CE, Lee KE, Gangnon R, Klein BE. Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy. Arch Ophthalmol 2012;130:749-755.
158. Wong TY. Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: Time to take out the measuring tape. Arch Ophthalmol 2011;129:95-96.
159. Youm DJ, Ha MM, Chang Y, Song SJ. Retinal vessel caliber and risk factors for branch retinal vein occlusion. Curr Eye Res 2012;37:334-338.
160. Pournaras CJ, Logean E, Riva CE, Petrig BL, Chamot SR, Coscas G, et al. Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 2006;47:1581-1586.
161. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS. Effect of isometric exercise on choroidal blood flow in patients with age-related macular degeneration. Br J Ophthalmol 2010;94:1629-1631.
162. Portmann N, Gugleta K, Kochkorov A, Polunina A, Flammer J, Orgul S. Choroidal blood flow response to isometric exercise in glaucoma patients and patients with ocular hypertension. Invest Ophthalmol Vis Sci 2011;52: 7068-7073.
163. Movaffaghy A, Chamot SR, Dosso A, Pournaras CJ, Sommerhalder JR, Riva CE. Effect of isometric exercise on choroidal blood flow in type I diabetic patients. Klin Monbl Augenheilkd 2002;219:299-301.
164. Frederiksen CA, Jeppesen P, Knudsen ST, Poulsen PL, Mogensen CE, Bek T. The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 2006;244:1255-1261.
165. Ustymowicz A, Mariak Z, Weigele J, Lyson T, Kochanowicz J, Krejza J. Normal reference intervals and ranges of side-to-side and day-to-day variability of ocular blood flow Doppler parameters. Ultrasound Med Biol 2005;31:895-903.
166. Kavroulaki D, Gugleta K, Kochkorov A, Katamay R, Flammer J, Orgul S. Influence of gender and menopausal status on peripheral and choroidal circulation. Acta Ophthalmol 2010;88:850-853.
167. Centofanti M, Bonini S, Manni G, Guinetti-Neuschuler C, Bucci MG, Harris A. Do sex and hormonal status influence choroidal circulation? Br J Ophthalmol 2000; 84:786-787.
168. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci 2003;44: 4644-4650.
169. Faria AF, de Souza MA, Geber S. Vascular resistance of central retinal artery is reduced in postmenopausal women after use of estrogen. Menopause 2011;18:869-872.
170. Harris-Yitzhak M, Harris A, Ben-Refael Z, Zarfati D, Garzozi HJ, Martin BJ. Estrogen-replacement therapy: Effects on retrobulbar hemodynamics. Am J Ophthalmol 2000;129:623-628.
171. Toker E, Yenice O, Akpinar I, Aribal E, Kazokoglu H. The influence of sex hormones on ocular blood flow in women. Acta Ophthalmol Scand 2003;81:617-624.
172. Deschenes MC, Descovich D, Moreau M, Granger L, Kuchel GA, Mikkola TS, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2010; 51:2587-2600.
173. Siesky B, Harris A, Kheradiya N, Ehrlich R, Klaas C, Kaplan B, et al. The effects of raloxifene hydrochloride on ocular hemodynamics and visual function. Int Ophthalmol 2009;29:225-230.
174. Leung FP, Tsang SY, Wong CM, Yung LM, Chan YC, Leung HS, et al. Raloxifene, tamoxifen and vascular tone. Clin Exp Pharmacol Physiol 2007;34:809-813.
175. Ciccone MM, Scicchitano P, Cortese F, Gesualdo M, Zito A, Tesorio M, et al. Modulation of vascular tone control under isometric muscular stress: Role of estrogen receptors. Vascul Pharmacol 2013;58:127-133.
176. Zavratnik A, Zegura B, Marc J, Prezelj J, Pfeifer M. XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function. Maturitas 2010;67:84-90.
177. Wong TY, Knudtson MD, Klein BE, Klein R, Hubbard LD. Estrogen replacement therapy and retinal vascular caliber. Ophthalmology 2005;112:553-558.
178. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Does hormone replacement therapy influence retinal microvascular caliber? Microvasc Res 2004;67: 48-54.
179. Souza MA, Souza BM, Geber S. Progesterone increases resistance of ophthalmic and central retinal arteries in climacteric women. Climacteric 2013;16:284-287.
180. Viana LC, Faria M, Pettersen H, Sampaio M, Geber S. Menstrual phase-related differences in the pulsatility index on the central retinal artery suggest an oestrogen vasodilatation effect that antagonizes with progesterone. Arch Gynecol Obstet 2011;283:569-573.
181. Tedeschi-Reiner E, Ivekovic R, Novak-Laus K, Reiner Z. Endogenous steroid sex hormones and atherosclerosis of retinal arteries in men. Med Sci Monit 2009;15:CR211-6.
182. Polak K, Luksch A, Berisha F, Fuchsjaeger-Mayrl G, Dallinger S, Schmetterer L. Altered nitric oxide system in patients with open-angle glaucoma. Arch Ophthalmol 2007;125:494-498.
183. Tostes RC, Fortes ZB, Callera GE, Montezano AC, Touyz RM, Webb RC, et al. Endothelin, sex and hypertension. Clin Sci (Lond) 2008;114:85-97.
184. Boltz A, Schmidl D, Werkmeister RM, Lasta M, Kaya S, Palkovits S, et al. Role of endothelin-A receptors in optic nerve head red cell flux regulation during isometric exercise in healthy humans. Am J Physiol Heart Circ Physiol 2013;304:H170-4.